Somewhat Critical Press Coverage Somewhat Unlikely to Impact Microbot Medical (NASDAQ:MBOT) Share Price

Share on StockTwits

Media stories about Microbot Medical (NASDAQ:MBOT) have been trending somewhat negative this week, Accern Sentiment reports. The research group scores the sentiment of news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Microbot Medical earned a daily sentiment score of -0.10 on Accern’s scale. Accern also assigned press coverage about the biotechnology company an impact score of 46.6272649071383 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

NASDAQ MBOT traded down $0.25 during mid-day trading on Friday, reaching $5.77. 23,085 shares of the stock were exchanged, compared to its average volume of 31,075. Microbot Medical has a 1-year low of $5.76 and a 1-year high of $22.80.

Microbot Medical (NASDAQ:MBOT) last announced its earnings results on Tuesday, August 14th. The biotechnology company reported ($0.04) earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of ($0.04). sell-side analysts anticipate that Microbot Medical will post -2.4 earnings per share for the current year.

MBOT has been the subject of several analyst reports. ValuEngine raised shares of Microbot Medical from a “hold” rating to a “buy” rating in a report on Thursday, September 6th. Zacks Investment Research raised shares of Microbot Medical from a “hold” rating to a “buy” rating and set a $1.00 price objective for the company in a research note on Thursday, May 31st.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures.

Featured Story: Do Tariffs Work?

Insider Buying and Selling by Quarter for Microbot Medical (NASDAQ:MBOT)

Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.